Labentrol

Ciprofloxacin Hydrochloride Monohydrate, the active ingredient in Labentrol, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats bacterial infections of the urinary, respiratory, skin and gastrointestinal tracts in adults and children as appropriate.

GNH USA supplies Labentrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Labentrol (ciprofloxacin) is a fluoroquinolone antibiotic that targets a broad range of bacterial pathogens in several organ systems.

- Urinary tract infections: eradicates common uropathogens and resolves symptoms. - Respiratory tract infections: treats community‑acquired pneumonia and bronchitis caused by susceptible bacteria. - Skin and soft tissue infections: clears bacterial cellulitis, abscesses and wound infections. - Gastrointestinal infections: manages bacterial gastroenteritis and travel‑related diarrhoea.

Ciprofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhoea: may be mild to moderate. - Headache: occasional tension‑type headache. - Dizziness: transient light‑headedness. - Rash: mild skin erythema. - Abdominal pain: cramping or discomfort.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, often linked to activity. - Peripheral neuropathy: sensory disturbances that may be irreversible. - Clostridioides difficile‑associated diarrhoea: severe colitis. - Severe allergic reactions: anaphylaxis or angioedema. - QT interval prolongation: risk of cardiac arrhythmias. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before prescribing Labentrol, clinicians should consider several safety factors.

- Renal function: adjust use in patients with severe renal impairment. - Age considerations: use caution in pediatric and elderly patients. - Photosensitivity: advise patients to avoid excessive sunlight exposure. - Drug resistance: limit use to confirmed bacterial infections to reduce resistance development. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Ciprofloxacin interacts with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce ciprofloxacin absorption. - Warfarin: may increase anticoagulant effect; monitor INR closely. - Theophylline: increased plasma levels can lead to toxicity.

Moderate Interactions (Monitor Closely): - Nonsteroidal anti‑inflammatory drugs (NSAIDs): may increase risk of central nervous system stimulation. - Corticosteroids: heightened risk of tendon rupture. - Diabetes medications (e.g., insulin, sulfonylureas): may affect glucose control.